Global Custom Market Research Reports Provider Company

phone

Inotek Pharmaceuticals Corp (ITEK) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Inotek Pharmaceuticals Corp (IPC) is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye. The companys trabodenoson is a selective adenosine mimetic that stimulates a specific adenosine subreceptor. Its product pipeline include fixed dose combination that comprises trabodenoson plus latanoprost in an eye drop formulation. The company has three pharmacologic targets for intervention (adenosine, PARP, and reactive oxygen species including peroxynitrite), which regulates as cellular responses to tissue stress or injury. IPC is headquartered in Lexington, Massachusetts, the US.

Inotek Pharmaceuticals Corp Key Recent Developments

Aug 03,2017: Inotek Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights
May 10,2017: Inotek Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights
Mar 16,2017: Inotek Pharmaceuticals Reports Fiscal Year 2016 Financial Results and Operational Highlights

This comprehensive SWOT profile of Inotek Pharmaceuticals Corp provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Inotek Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Inotek Pharmaceuticals Corp - Key Information
Inotek Pharmaceuticals Corp - Overview
Inotek Pharmaceuticals Corp - Key Employees
Inotek Pharmaceuticals Corp - Key Employee Biographies
Inotek Pharmaceuticals Corp - Key Operational Heads
Inotek Pharmaceuticals Corp - Major Products and Services
Inotek Pharmaceuticals Corp - History
Inotek Pharmaceuticals Corp - Company Statement
Inotek Pharmaceuticals Corp - Locations And Subsidiaries
Inotek Pharmaceuticals Corp - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Inotek Pharmaceuticals Corp - Business Description
Inotek Pharmaceuticals Corp - Corporate Strategy
Inotek Pharmaceuticals Corp - SWOT Analysis
SWOT Analysis - Overview
Inotek Pharmaceuticals Corp - Strengths
Inotek Pharmaceuticals Corp - Weaknesses
Inotek Pharmaceuticals Corp - Opportunities
Inotek Pharmaceuticals Corp - Threats
Inotek Pharmaceuticals Corp - Key Competitors

Section 3 - Company Financial Performance Charts

Inotek Pharmaceuticals Corp - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Inotek Pharmaceuticals Corp, Key Information
Inotek Pharmaceuticals Corp, Key Ratios
Inotek Pharmaceuticals Corp, Share Data
Inotek Pharmaceuticals Corp, Major Products and Services
Inotek Pharmaceuticals Corp, History
Inotek Pharmaceuticals Corp, Key Employees
Inotek Pharmaceuticals Corp, Key Employee Biographies
Inotek Pharmaceuticals Corp, Key Operational Heads
Inotek Pharmaceuticals Corp, Other Locations
Inotek Pharmaceuticals Corp, Subsidiaries
Inotek Pharmaceuticals Corp, Key Manufacturing facilities
Inotek Pharmaceuticals Corp, Key Competitors
Inotek Pharmaceuticals Corp, SWOT Analysis
Inotek Pharmaceuticals Corp, Ratios based on current share price
Inotek Pharmaceuticals Corp, Annual Ratios
Inotek Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Inotek Pharmaceuticals Corp, Performance Chart
Inotek Pharmaceuticals Corp, Ratio Charts

Inotek Pharmaceuticals Corp (IPC) is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye. The companys trabodenoson is a

View Report

Inotek Pharmaceuticals Corp (IPC) is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye. The companys trabodenoson is a

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports